ResMed

ResMed

ResMed was founded in 1989 by Dr. Peter Farrell, a mechanical engineer who commercialized the nasal continuous positive airway pressure (CPAP) mask after leaving the University of New South Wales. The company relocated to San Diego early in its life and went public in 1995. From the start, ResMed fused clinical respiratory science with consumer-electronics design, a combination that would later draw its mask units into bedrooms across North America, Europe, and Asia-Pacific. Today the firm operates across three interlocking business lines: sleep devices, respiratory-care ventilators, and a growing software-as-a-service layer that supports out-of-hospital care settings. Its hardware portfolio spans CPAP and bilevel positive airway pressure machines, non-invasive ventilators, and disposable mask systems, while its SaaS unit—anchored by the Brightree and MatrixCare platforms—handles billing, scheduling, and clinical documentation for home medical equipment providers and skilled nursing facilities. In the consumer channel, ResMed's myAir mobile application delivers nightly adherence scores to individual CPAP users, and a 2024 partnership with health-ring maker ŌURA links sleep-apnea population data to daily rest-and-readiness metrics. ResMed employs more than 10,000 people worldwide and ships products to over 140 countries. Manufacturing is clustered in Australia, Singapore, and the United States, while a dedicated residential-care software team builds for post-acute facilities. The company does not disclose a formal philanthropic vehicle or a family-office attachment, and no co-investing clubs or multi-family structures are tied to its corporate balance sheet. In October 2024, ResMed expanded its digital footprint by integrating the ŌURA ring's sleep-stage data directly into the myAir app, a move that extends the firm's post-diagnosis relationship from the bedside to the wrist. ResMed's structural differentiator is the reimbursement-driven moat it has built around its connected devices. Because US payors require objective adherence data to fund ongoing CPAP supplies, ResMed's cloud-connected machines—which beam nightly usage data to physicians, durable medical equipment suppliers, and insurance plans—act as a de facto compliance toll gate, locking in recurring mask and accessory revenue per patient. That dynamic makes the company behave less like a durable-goods manufacturer and more like a digitally enforced annuity, a posture few medical-device peers can replicate.